The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
3,4-dichloro-2-(2-(methoxymethyl)cyclopropyl)-1-(piperidin-3-yl)-1H-pyrrolo[2,3-b]pyridine-6-carboxamide ID: ALA4090269
PubChem CID: 137643747
Max Phase: Preclinical
Molecular Formula: C18H22Cl2N4O2
Molecular Weight: 397.31
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: COCC1CC1c1c(Cl)c2c(Cl)cc(C(N)=O)nc2n1C1CCCNC1
Standard InChI: InChI=1S/C18H22Cl2N4O2/c1-26-8-9-5-11(9)16-15(20)14-12(19)6-13(17(21)25)23-18(14)24(16)10-3-2-4-22-7-10/h6,9-11,22H,2-5,7-8H2,1H3,(H2,21,25)
Standard InChI Key: VNPQQGXWMYSECL-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 29 0 0 0 0 0 0 0 0999 V2000
38.0599 -27.3016 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.0587 -28.1211 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.7668 -28.5301 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
38.7650 -26.8927 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.4736 -27.2980 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.4784 -28.1166 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.2584 -28.3650 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
40.7358 -27.6999 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.2507 -27.0405 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.3507 -28.5292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.6433 -28.1200 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
37.3501 -29.3463 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
38.7626 -26.0755 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
40.5155 -29.1408 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.4987 -26.2619 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
39.9698 -29.7467 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.2239 -30.5196 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.0237 -30.6891 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.5690 -30.0792 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
41.3146 -29.2999 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.5537 -27.6937 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.2638 -28.0982 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.2590 -27.2810 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.6766 -28.8035 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.4937 -28.7986 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
43.9065 -29.5039 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 2 0
9 5 1 0
2 10 1 0
10 11 2 0
10 12 1 0
4 13 1 0
7 14 1 0
9 15 1 0
14 16 1 0
14 20 1 0
16 17 1 0
17 18 1 0
18 19 1 0
19 20 1 0
22 21 1 0
23 22 1 0
21 23 1 0
8 21 1 0
22 24 1 0
24 25 1 0
25 26 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 397.31Molecular Weight (Monoisotopic): 396.1120AlogP: 3.12#Rotatable Bonds: 5Polar Surface Area: 82.17Molecular Species: BASEHBA: 5HBD: 2#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 10.01CX LogP: 2.19CX LogD: -0.33Aromatic Rings: 2Heavy Atoms: 26QED Weighted: 0.81Np Likeness Score: -0.18
References 1. Barberis C, Moorcroft N, Pribish J, Tserlin E, Gross A, Czekaj M, Barrague M, Erdman P, Majid T, Batchelor J, Levit M, Hebert A, Shen L, Moreno-Mazza S, Wang A.. (2017) Discovery of N-substituted 7-azaindoles as Pan-PIM kinase inhibitors - Lead series identification - Part II., 27 (20): [PMID:28927793 ] [10.1016/j.bmcl.2017.08.068 ]